Skip to main content
. Author manuscript; available in PMC: 2012 May 1.
Published in final edited form as: J Thorac Cardiovasc Surg. 2011 Nov 3;143(2):495–502. doi: 10.1016/j.jtcvs.2011.09.023

Table 4.

Risk Discrimination and Continuous Net Reclassification Index for stage I and II AKI by UACR and Urine dipstick measurements

Stage I AKI Stage II AKI
Area Under the ROC Curve (SE)
Albuminuria 0.604 (0.017) 0.591 (0.036)
 Clinical Model 0.669 (0.017) 0.723 (0.036)
 Clinical Model + Albuminuria 0.695 (0.016) 0.731 (0.037)
 p-value* 0.0055 0.50
Dipstick 0.573 (0.016) 0.573 (0.036)
 Clinical Model 0.673 (0.017) 0.728 (0.036)
 Clinical Model + Dipstick 0.688 (0.017) 0.732 (0.037)
 p-value* 0.0272 0.70
Continuous Net Reclassification Index (SE)
Albuminuria 0.289 (0.062) 0.290 (0.135)
 p-value <.0001 0.0312
Dipstick 0.248 (0.063) 0.285 (0.135)
 p-value <.0001 0.0347

Clinical model includes age (per year), sex, white, pre-op eGFR (per mL/min per 1.73 m2), diabetes, elective surgery, hypertension, chronic heart failure, cardiac catheterization in past 48 hours, myocardial infarction, and type of surgery.

*

p-value comparing the addition of albuminuria to the clinical model

p-value comparing the addition of dipstick to the clinical model

Abbreviations: ROC- receiver operating curve, AKI- acute kidney injury, UACR- urine albumin to creatinine ratio, SE- standard error